Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4+ T cells

Molecular Therapy

Volumn 20, Issue 9, 2012, Pages 1778-1790

  Andolfi, Grazia ^a   Fousteri, Georgia ^a   Rossetti, Maura ^a,b   Magnani, Chiara F ^a   Jofra, Tatiana ^c   Locafaro, Grazia ^a   Bondanza, Attilio ^c   Gregori, Silvia ^a   Roncarolo, Maria Grazia ^a,b  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; LENTIVIRUS VECTOR; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL CONTACT; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL THERAPY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENETIC TRANSDUCTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REGULATORY T LYMPHOCYTE TYPE 1;

EID: 84867039778     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.71     Document Type: Article

References (50)

1. Saraiva, M and O'Garra, A (2010). The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
2. de Waal Malefyt, R, Abrams, J, Bennett, B, Figdor, CG and de Vries, JE (1991). Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220.
3. Fiorentino, DF, Zlotnik, A, Mosmann, TR, Howard, M and O'Garra, A (1991). IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822.
4. Taga, K, Mostowski, H and Tosato, G (1993). Human interleukin-10 can directly inhibit T-cell growth. Blood 81: 2964-2971. (Pubitemid 23162114)
5. de Waal Malefyt, R, Yssel, H and de Vries, JE (1993). Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specifc inhibition of IL-2 production and proliferation. J Immunol 150: 4754-4765. (Pubitemid 23150343)
6. Jinquan, T, Quan, S, Jacobi, HH, Madsen, HO, Glue, C, Skov, PS et al. (2000). CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10. Immunology 99: 402-410. (Pubitemid 30137705)
7. Groux, H, Bigler, M, de Vries, JE and Roncarolo, MG (1996). Interleukin-10 induces a long-term antigen-specifc anergic state in human CD4+ T cells. J Exp Med 184: 19-29. (Pubitemid 26247211)
8. Groux, H, O'Garra, A, Bigler, M, Rouleau, M, Antonenko, S, de Vries, JE et al. (1997). A CD4+ T-cell subset inhibits antigen-specifc T-cell responses and prevents colitis. Nature 389: 737-742. (Pubitemid 27458961)
9. Roncarolo, MG, Gregori, S, Battaglia, M, Bacchetta, R, Fleischhauer, K and Levings, MK (2006). Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212: 28-50. (Pubitemid 44116698)
10. Roncarolo, MG, Yssel, H, Touraine, JL, Bacchetta, R, Gebuhrer, L, De Vries, JE et al. (1988). Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J Exp Med 168: 2139-2152. (Pubitemid 19020895)
11. Bacchetta, R, Bigler, M, Touraine, JL, Parkman, R, Tovo, PA, Abrams, J et al. (1994). High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 179: 493-502. (Pubitemid 24058737)
12. Serafni, G, Andreani, M, Testi, M, Battarra, M, Bontadini, A, Biral, E et al. (2009). Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia. Haematologica 94: 1415-1426.
13. Bacchetta, R, Sartirana, C, Levings, MK, Bordignon, C, Narula, S and Roncarolo, MG (2002). Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 32: 2237-2245. (Pubitemid 34965886)
14. Magnani, CF, Alberigo, G, Bacchetta, R, Serafni, G, Andreani, M, Roncarolo, MG et al. (2011). Killing of myeloid APCs via HLA class I, CD2 and CD226 defnes a novel mechanism of suppression by human Tr1 cells. Eur J Immunol 41: 1652-1662.
15. Di Ianni, M, Falzetti, F, Carotti, A, Terenzi, A, Castellino, F, Bonifacio, E et al. (2011). Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117: 3921-3928.
16. Brunstein, CG, Miller, JS, Cao, Q, McKenna, DH, Hippen, KL, Curtsinger, J et al. (2011). Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profle and detection kinetics. Blood 117: 1061-1070.
17. Bacchetta, R, Sartirana, C, Lucarelli, B, Miqueu, P, Lupo Stanghellini, M T, Greco, R et al. (2009). Interleukin-10 anergized donor T cell infusion improves immune reconstitution without severe graft-versus-host disease after haploidentical hematopoietic stem cell transplantation. Blood 114: 45 (ASH Annual Meeting Abstract).
18. Levings, MK, Sangregorio, R, Galbiati, F, Squadrone, S, de Waal Malefyt, R and Roncarolo, MG (2001). IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166: 5530-5539. (Pubitemid 32374175)
19. Barrat, FJ, Cua, DJ, Boonstra, A, Richards, D F, Crain, C, Savelkoul, HF et al. (2002). In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J Exp Med 195: 603-616. (Pubitemid 34461505)
20. Kemper, C, Chan, AC, Green, JM, Brett, KA, Murphy, KM and Atkinson, JP (2003). Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392. (Pubitemid 36157938)
21. Pot, C, Jin, H, Awasthi, A, Liu, SM, Lai, CY, Madan, R et al. (2009). Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 183: 797-801.
22. Levings, MK, Gregori, S, Tresoldi, E, Cazzaniga, S, Bonini, C and Roncarolo, MG (2005). Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105: 1162-1169. (Pubitemid 40170889)
23. Bacchetta, R, Gregori, S, Serafni, G, Sartirana, C, Schulz, U, Zino, E et al. (2010). Molecular and functional characterization of allogantigen-specifc anergic T cells suitable for cell therapy. Haematologica 95: 2134-2143.
24. Gregori, S, Tomasoni, D, Pacciani, V, Scirpoli, M, Battaglia, M, Magnani, CF et al. (2010). Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116: 935-944.
25. Ito, T, Yang, M, Wang, YH, Lande, R, Gregorio, J, Perng, OA et al. (2007). Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 204: 105-115. (Pubitemid 46148761)
26. Brandt, C, Yang, J, Schmitt-Knosalla, I, Siepert, A, Hammer, MH, Vogt, K et al. (2005). Allo-specifc T-cells encoding for viral IL-10 exert strong immunomodulatory effects in vitro but fail to prevent graft rejection. Am J Transplant 5: 268-281. (Pubitemid 40179513)
27. Setoguchi, K, Misaki, Y, Araki, Y, Fujio, K, Kawahata, K, Kitamura, T et al. (2000). Antigen-specifc T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen. J Immunol 165: 5980-5986.
28. Guichelaar, T, ten Brink, CB, van Kooten, PJ, Berlo, SE, Broeren, CP, van Eden, W et al. (2008). Autoantigen-specifc IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response. J Immunol 180: 1373-1381.
29. Van Montfrans, C, Rodriguez Pena, MS, Pronk, I, Ten Kate, FJ, Te Velde, AA and Van Deventer, SJ (2002). Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model. Gastroenterology 123: 1865-1876. (Pubitemid 35408311)
30. Oh, JW, Seroogy, CM, Meyer, EH, Akbari, O, Berry, G, Fathman, CG et al. (2002). CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and infammation. J Allergy Clin Immunol 110: 460-468.
31. Zhao, J, Pettigrew, GJ, Bolton, EM, Murftt, CR, Carmichael, A, Bradley, JA et al. (2005). Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection. Gene Ther 12: 1509-1516. (Pubitemid 41508676)
32. Trittibach, P, Barker, SE, Broderick, CA, Natkunarajah, M, Duran, Y, Robbie, SJ et al. (2008). Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitis. Gene Ther 15: 1478-1488.
33. Cavalieri, S, Cazzaniga, S, Geuna, M, Magnani, Z, Bordignon, C, Naldini, L et al. (2003). Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 102: 497-505. (Pubitemid 36841966)
34. Marktel, S, Magnani, Z, Ciceri, F, Cazzaniga, S, Riddell, SR, Traversari, C et al. (2003). Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation. Blood 101: 1290-1298. (Pubitemid 36182498)
35. Amendola, M, Venneri, MA, Biff, A, Vigna, E and Naldini, L (2005). Coordinate dualgene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol 23: 108-116. (Pubitemid 41724633)
36. Akdis, M, Verhagen, J, Taylor, A, Karamloo, F, Karagiannidis, C, Crameri, R et al. (2004). Immune responses in healthy and allergic individuals are characterized by a fne balance between allergen-specifc T regulatory 1 and T helper 2 cells. J Exp Med 199: 1567-1575. (Pubitemid 38780411)
37. Häringer, B, Lozza, L, Steckel, B and Geginat, J (2009). Identifcation and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J Exp Med 206: 1009-1017.
38. Bondanza, A, Valtolina, V, Magnani, Z, Ponzoni, M, Fleischhauer, K, Bonyhadi, M et al. (2006). Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107: 1828-1836. (Pubitemid 43289360)
39. Misaki, Y, Setoguchi, K, Araki, Y, Fujio, K, Kawahata, K, Kitamura, T et al. (2000). [Antigen-specifc T cells transduced with interleukin-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen]. Nihon Rinsho Meneki Gakkai Kaishi 23: 538-541.
40. Bonini, C, Bondanza, A, Perna, SK, Kaneko, S, Traversari, C, Ciceri, F et al. (2007). The suicide gene therapy challenge: how to improve a successful gene therapy approach. Mol Ther 15: 1248-1252. (Pubitemid 46965319)
41. Montini, E, Cesana, D, Schmidt, M, Sanvito, F, Ponzoni, M, Bartholomae, C et al. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol 24: 687-696. (Pubitemid 43882120)
42. Frauwirth, KA and Thompson, CB (2004). Regulation of T lymphocyte metabolism. J Immunol 172: 4661-4665. (Pubitemid 38456383)
43. Battaglia, M, Stabilini, A, Draghici, E, Gregori, S, Mocchetti, C, Bonifacio, E et al. (2006). Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specifc transplantation tolerance. Diabetes 55: 40-49. (Pubitemid 43343297)
44. Brooks, DG, Triflo, MJ, Edelmann, KH, Teyton, L, McGavern, DB and Oldstone, MB (2006). Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 12: 1301-1309. (Pubitemid 44706933)
45. Ejrnaes, M, Filippi, CM, Martinic, MM, Ling, EM, Togher, LM, Crotty, S et al. (2006). Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203: 2461-2472. (Pubitemid 44664616)
46. McMurchy, AN, Bushell, A, Levings, MK and Wood, KJ (2011). Moving to tolerance: clinical application of T regulatory cells. Semin Immunol 23: 304-313.
47. Ciceri, F, Bonini, C, Stanghellini, MT, Bondanza, A, Traversari, C, Salomoni, M et al. (2009). Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. Lancet Oncol 10: 489-500.
48. De Palma, M and Naldini, L (2002). Transduction of a gene expression cassette using advanced generation lentiviral vectors. Meth Enzymol 346: 514-529. (Pubitemid 41103156)
49. Gentner, B, Schira, G, Giustacchini, A, Amendola, M, Brown, BD, Ponzoni, M et al. (2009). Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 6: 63-66.
50. Tanaka, T, Kitamura, F, Nagasaka, Y, Kuida, K, Suwa, H and Miyasaka, M (1993). Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med 178: 1103-1107. (Pubitemid 23260450)